vs
南玻集团（CSGS）与Privia Health Group, Inc.（PRVA）财务数据对比。点击上方公司名可切换其他公司
Privia Health Group, Inc.的季度营收约是南玻集团的1.7倍（$541.2M vs $323.1M），南玻集团净利率更高（2.2% vs 1.7%，领先0.5%），Privia Health Group, Inc.同比增速更快（17.4% vs 2.0%），过去两年Privia Health Group, Inc.的营收复合增速更高（14.2% vs 4.6%）
中国南玻集团股份有限公司是中国规模最大的建筑玻璃生产商，业务涵盖浮法玻璃、建筑玻璃、显示玻璃、汽车玻璃、镀膜玻璃、镜子、彩滤玻璃、太阳能玻璃及节能玻璃等各类玻璃产品的研发、生产与销售，产品广泛应用于建筑、消费电子、新能源汽车、光伏等多个领域。
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
CSGS vs PRVA — 直观对比
营收规模更大
PRVA
是对方的1.7倍
$323.1M
营收增速更快
PRVA
高出15.4%
2.0%
净利率更高
CSGS
高出0.5%
1.7%
两年增速更快
PRVA
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $323.1M | $541.2M |
| 净利润 | $7.0M | $9.2M |
| 毛利率 | 50.0% | — |
| 营业利润率 | 9.0% | 2.1% |
| 净利率 | 2.2% | 1.7% |
| 营收同比 | 2.0% | 17.4% |
| 净利润同比 | -79.7% | 108.0% |
| 每股收益（稀释后） | $0.24 | $0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSGSPRVA
| Q4 25 | $323.1M | $541.2M | ||
| Q3 25 | $303.6M | $580.4M | ||
| Q2 25 | $297.1M | $521.2M | ||
| Q1 25 | $299.5M | $480.1M | ||
| Q4 24 | $316.7M | $460.9M | ||
| Q3 24 | $295.1M | $437.9M | ||
| Q2 24 | $290.3M | $422.3M | ||
| Q1 24 | $295.1M | $415.2M |
净利润CSGSPRVA
| Q4 25 | $7.0M | $9.2M | ||
| Q3 25 | $20.5M | $6.9M | ||
| Q2 25 | $12.3M | $2.7M | ||
| Q1 25 | $16.1M | $4.2M | ||
| Q4 24 | $34.5M | $4.4M | ||
| Q3 24 | $19.1M | $3.5M | ||
| Q2 24 | $13.8M | $3.5M | ||
| Q1 24 | $19.5M | $3.0M |
毛利率CSGSPRVA
| Q4 25 | 50.0% | — | ||
| Q3 25 | 48.1% | — | ||
| Q2 25 | 49.5% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | 51.3% | — | ||
| Q3 24 | 49.4% | — | ||
| Q2 24 | 47.3% | — | ||
| Q1 24 | 46.5% | — |
营业利润率CSGSPRVA
| Q4 25 | 9.0% | 2.1% | ||
| Q3 25 | 10.0% | 2.5% | ||
| Q2 25 | 10.0% | 0.6% | ||
| Q1 25 | 9.8% | 1.1% | ||
| Q4 24 | 13.4% | 1.1% | ||
| Q3 24 | 10.8% | 1.3% | ||
| Q2 24 | 8.8% | 1.2% | ||
| Q1 24 | 10.8% | 0.2% |
净利率CSGSPRVA
| Q4 25 | 2.2% | 1.7% | ||
| Q3 25 | 6.7% | 1.2% | ||
| Q2 25 | 4.1% | 0.5% | ||
| Q1 25 | 5.4% | 0.9% | ||
| Q4 24 | 10.9% | 1.0% | ||
| Q3 24 | 6.5% | 0.8% | ||
| Q2 24 | 4.8% | 0.8% | ||
| Q1 24 | 6.6% | 0.7% |
每股收益（稀释后）CSGSPRVA
| Q4 25 | $0.24 | $0.08 | ||
| Q3 25 | $0.73 | $0.05 | ||
| Q2 25 | $0.44 | $0.02 | ||
| Q1 25 | $0.57 | $0.03 | ||
| Q4 24 | $1.20 | $0.03 | ||
| Q3 24 | $0.67 | $0.03 | ||
| Q2 24 | $0.48 | $0.03 | ||
| Q1 24 | $0.68 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.0M | $479.7M |
| 总债务越低越好 | $539.5M | — |
| 股东权益账面价值 | $283.7M | $737.2M |
| 总资产 | $1.5B | $1.4B |
| 负债/权益比越低杠杆越低 | 1.90× | — |
8季度趋势，按日历期对齐
现金及短期投资CSGSPRVA
| Q4 25 | $180.0M | $479.7M | ||
| Q3 25 | $158.4M | $441.4M | ||
| Q2 25 | $145.9M | $390.1M | ||
| Q1 25 | $136.0M | $469.3M | ||
| Q4 24 | $161.8M | $491.1M | ||
| Q3 24 | $118.4M | $422.0M | ||
| Q2 24 | $110.4M | $387.4M | ||
| Q1 24 | $120.8M | $351.1M |
总债务CSGSPRVA
| Q4 25 | $539.5M | — | ||
| Q3 25 | $538.6M | — | ||
| Q2 25 | $537.8M | — | ||
| Q1 25 | $537.6M | — | ||
| Q4 24 | $538.5M | — | ||
| Q3 24 | $539.5M | — | ||
| Q2 24 | $540.5M | — | ||
| Q1 24 | $541.5M | — |
股东权益CSGSPRVA
| Q4 25 | $283.7M | $737.2M | ||
| Q3 25 | $289.5M | $709.1M | ||
| Q2 25 | $290.7M | $682.9M | ||
| Q1 25 | $283.1M | $659.4M | ||
| Q4 24 | $282.6M | $635.2M | ||
| Q3 24 | $288.4M | $614.9M | ||
| Q2 24 | $273.3M | $595.4M | ||
| Q1 24 | $269.3M | $576.8M |
总资产CSGSPRVA
| Q4 25 | $1.5B | $1.4B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.5B | $1.1B | ||
| Q3 24 | $1.4B | $1.1B | ||
| Q2 24 | $1.4B | $1.1B | ||
| Q1 24 | $1.3B | $1.0B |
负债/权益比CSGSPRVA
| Q4 25 | 1.90× | — | ||
| Q3 25 | 1.86× | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.90× | — | ||
| Q4 24 | 1.91× | — | ||
| Q3 24 | 1.87× | — | ||
| Q2 24 | 1.98× | — | ||
| Q1 24 | 2.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $59.2M | $127.5M |
| 自由现金流经营现金流 - 资本支出 | $55.8M | — |
| 自由现金流率自由现金流/营收 | 17.3% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | 8.46× | 13.93× |
| 过去12个月自由现金流最近4个季度 | $141.4M | — |
8季度趋势，按日历期对齐
经营现金流CSGSPRVA
| Q4 25 | $59.2M | $127.5M | ||
| Q3 25 | $47.9M | $52.0M | ||
| Q2 25 | $37.3M | $8.0M | ||
| Q1 25 | $11.5M | $-24.1M | ||
| Q4 24 | $82.5M | $74.8M | ||
| Q3 24 | $39.5M | $33.2M | ||
| Q2 24 | $43.1M | $34.5M | ||
| Q1 24 | $-29.4M | $-33.1M |
自由现金流CSGSPRVA
| Q4 25 | $55.8M | — | ||
| Q3 25 | $43.9M | — | ||
| Q2 25 | $34.6M | — | ||
| Q1 25 | $7.1M | — | ||
| Q4 24 | $76.6M | — | ||
| Q3 24 | $32.0M | — | ||
| Q2 24 | $38.8M | — | ||
| Q1 24 | $-34.1M | — |
自由现金流率CSGSPRVA
| Q4 25 | 17.3% | — | ||
| Q3 25 | 14.5% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 13.4% | — | ||
| Q1 24 | -11.6% | — |
资本支出强度CSGSPRVA
| Q4 25 | 1.1% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.6% | — |
现金转化率CSGSPRVA
| Q4 25 | 8.46× | 13.93× | ||
| Q3 25 | 2.34× | 7.58× | ||
| Q2 25 | 3.04× | 2.97× | ||
| Q1 25 | 0.71× | -5.70× | ||
| Q4 24 | 2.39× | 17.00× | ||
| Q3 24 | 2.07× | 9.38× | ||
| Q2 24 | 3.12× | 9.94× | ||
| Q1 24 | -1.51× | -11.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
